These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 19952032)
1. Viable iPSC mice: a step closer to therapeutic applications in humans? Betts DH; Kalionis B Mol Hum Reprod; 2010 Feb; 16(2):57-62. PubMed ID: 19952032 [TBL] [Abstract][Full Text] [Related]
2. More synergetic cooperation of Yamanaka factors in induced pluripotent stem cells than in embryonic stem cells. Huang J; Chen T; Liu X; Jiang J; Li J; Li D; Liu XS; Li W; Kang J; Pei G Cell Res; 2009 Oct; 19(10):1127-38. PubMed ID: 19736564 [TBL] [Abstract][Full Text] [Related]
3. Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells. Zhou W; Freed CR Stem Cells; 2009 Nov; 27(11):2667-74. PubMed ID: 19697349 [TBL] [Abstract][Full Text] [Related]
4. Expression and activation of the reprogramming transcription factors. Guo J; Li ZC; Feng YH Biochem Biophys Res Commun; 2009 Dec; 390(4):1081-6. PubMed ID: 19900408 [TBL] [Abstract][Full Text] [Related]
9. Induced adult stem (iAS) cells and induced transit amplifying progenitor (iTAP) cells-a possible alternative to induced pluripotent stem (iPS) cells? Heng BC; Richards M; Ge Z; Shu Y J Tissue Eng Regen Med; 2010 Feb; 4(2):159-62. PubMed ID: 19967742 [TBL] [Abstract][Full Text] [Related]
10. Derivation of murine induced pluripotent stem cells (iPS) and assessment of their differentiation toward osteogenic lineage. Li F; Bronson S; Niyibizi C J Cell Biochem; 2010 Mar; 109(4):643-52. PubMed ID: 20039314 [TBL] [Abstract][Full Text] [Related]
11. Induced pluripotent stem cells: current progress and potential for regenerative medicine. Amabile G; Meissner A Trends Mol Med; 2009 Feb; 15(2):59-68. PubMed ID: 19162546 [TBL] [Abstract][Full Text] [Related]
12. Induction of pluripotency by defined factors. Okita K; Yamanaka S Exp Cell Res; 2010 Oct; 316(16):2565-70. PubMed ID: 20420827 [TBL] [Abstract][Full Text] [Related]
14. Generation of parthenogenetic induced pluripotent stem cells from parthenogenetic neural stem cells. Do JT; Joo JY; Han DW; Araúzo-Bravo MJ; Kim MJ; Greber B; Zaehres H; Sobek-Klocke I; Chung HM; Schöler HR Stem Cells; 2009 Dec; 27(12):2962-8. PubMed ID: 19816953 [TBL] [Abstract][Full Text] [Related]
15. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Huangfu D; Osafune K; Maehr R; Guo W; Eijkelenboom A; Chen S; Muhlestein W; Melton DA Nat Biotechnol; 2008 Nov; 26(11):1269-75. PubMed ID: 18849973 [TBL] [Abstract][Full Text] [Related]
16. The promise of human induced pluripotent stem cells for research and therapy. Nishikawa S; Goldstein RA; Nierras CR Nat Rev Mol Cell Biol; 2008 Sep; 9(9):725-9. PubMed ID: 18698329 [TBL] [Abstract][Full Text] [Related]
17. AID in reprogramming: quick and efficient: identification of a key enzyme called AID, and its activity in DNA demethylation, may help to overcome a pivotal epigenetic barrier in reprogramming somatic cells toward pluripotency. Deng W Bioessays; 2010 May; 32(5):385-7. PubMed ID: 20394066 [TBL] [Abstract][Full Text] [Related]
18. Pluripotency can be rapidly and efficiently induced in human amniotic fluid-derived cells. Li C; Zhou J; Shi G; Ma Y; Yang Y; Gu J; Yu H; Jin S; Wei Z; Chen F; Jin Y Hum Mol Genet; 2009 Nov; 18(22):4340-9. PubMed ID: 19679563 [TBL] [Abstract][Full Text] [Related]
19. Clone- and gene-specific aberrations of parental imprinting in human induced pluripotent stem cells. Pick M; Stelzer Y; Bar-Nur O; Mayshar Y; Eden A; Benvenisty N Stem Cells; 2009 Nov; 27(11):2686-90. PubMed ID: 19711451 [TBL] [Abstract][Full Text] [Related]
20. Cell reprogramming: expectations and challenges for chemistry in stem cell biology and regenerative medicine. Anastasia L; Pelissero G; Venerando B; Tettamanti G Cell Death Differ; 2010 Aug; 17(8):1230-7. PubMed ID: 20168332 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]